Illness, N.I.o.D.a.D.a.Ok. What’s diabetes? 2023 [cited 2023 October 20]; Out there from: https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes.
Zhang S, Staples AE. Microfluidic-based methods for the administration of diabetes. Drug Deliv Transl Res. 2024;14:2989.
Saeedi P, et al. International and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: outcomes from the Worldwide Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. 2019;157: 107843.
Saeedi P, et al. Mortality attributable to diabetes in 20–79 years previous adults, 2019 estimates: outcomes from the Worldwide Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. 2020;162: 108086.
Mobasseri M, et al. Prevalence and incidence of sort 1 diabetes on the planet: a scientific overview and meta-analysis. Well being Promot Perspect. 2020;10(2):98–115.
Collaborators GD. International, regional, and nationwide burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: asystematic evaluation for the International Burden of Illness Examine 2021. The Lancet. 2023;402(10397):31.
Di Pietrantonio N, et al. Function of epigenetics and metabolomics in predicting endothelial dysfunction in sort 2 diabetes. Adv Biol (Weinh). 2023;7(9): e2300172.
Nørlev JTD, et al. Quantification of insulin adherence in adults with insulin-treated sort 2 diabetes: a scientific overview. Diabetes Metab Syndr. 2023;17(12): 102908.
Li SH, et al. Steel-polyphenol microgels for oral supply of puerarin to alleviate the onset of diabetes. Drug Deliv Transl Res. 2024;14(3):757–72.
Tan SY, et al. Kind 1 and a pair of diabetes mellitus: a overview on present therapy method and gene remedy as potential intervention. Diabetes Metab Syndr. 2019;13(1):364–72.
Yoon J-W, Jun H-S. Current advances in insulin gene remedy for sort 1 diabetes. Traits Mol Med. 2002;8(2):6.
Kono TM, et al. Human adipose-derived stromal/stem cells shield towards STZ-induced hyperglycemia: evaluation of hASC-derived paracrine effectors. Stem Cells. 2014;32(7):1831–42.
Sher EK, et al. Novel therapeutical approaches based mostly on neurobiological and genetic methods for diabetic polyneuropathy—a overview. Diabetes Metab Syndr. 2023;17(11): 102901.
El Maalouf IR, Capoccia Ok, Priefer R. Non-invasive methods of administering insulin. Diabetes Metab Syndr. 2022;16(4): 102478.
Lopes M, et al. Why most oral insulin formulations don’t attain medical trials. Ther Deliv. 2015;6(8):973–87.
Arora S, et al. Early detection of cutaneous problems of insulin remedy in sort 1 and sort 2 diabetes mellitus. Prim Care Diabetes. 2021;15(5):859–64.
Richardson T, Kerr D. Pores and skin-related problems of insulin remedy: epidemiology and rising administration methods. Am J Clin Dermatol. 2003;4(10):661–7.
Hammad RW, et al. Cubosomal functionalized block copolymer platform for twin supply of linagliptin and empagliflozin: current advances in synergistic methods for maximizing management of high-risk sort II diabetes. Drug Deliv Transl Res. 2024;14(3):678–95.
Trief PM, et al. Incorrect insulin administration: an issue that warrants consideration. Clin Diabetes. 2016;34(1):25–33.
DiMeglio LA, Evans-Molina C, Oram RA. Kind 1 diabetes. Lancet J. 2018;391(10138):2449–62.
Zheng Y, Ley SH, Hu FB. International aetiology and epidemiology of sort 2 diabetes mellitus and its problems. Nat Rev Endocrinol. 2018;14(2):88–98.
Pandey V, et al. Chapter 18—excipient toxicity and security. In: Tekade RK, editor., et al., Pharmacokinetics and toxicokinetic issues. New York: Educational Press; 2022. p. 487–511.
Sharma S, Parveen R, Chatterji BP. Toxicology of nanoparticles in drug supply. Curr Pathobiol Rep. 2021;9(4):133–44.
Gil AG, et al. Toxicity and biodistribution of orally administered casein nanoparticles. Meals Chem Toxicol. 2017;106(Pt A):477–86.
Harugade A, Sherje A, Pethe A. Chitosan: a overview on properties, organic actions and up to date progress in biomedical functions. React Funct Polym. 2023;1991.
Wang W, et al. Chitosan derivatives and their utility in biomedicine. Int J Mol Sci. 2020;21(2):487.
Xu J, et al. Chitosan-microcapsulated insulin alleviates mesenteric microcirculation dysfunction by way of modulating COX-2 and VCAM-1 expression in rats with diabetes mellitus. Int J Nanomed. 2018;13:6829–37.
Tian H, et al. Uniform core–shell nanoparticles with thiolated hyaluronic acid coating to boost oral supply of insulin. Adv Healthc Mater. 2018;7(17): e1800285.
Agrawal A, et al. Folate appended chitosan nanoparticles increase the soundness, bioavailability and efficacy of insulin in diabetic rats following oral administration. RSC Adv. 2015;5:105179–93.
Papakostidis C, Giannoudis PV. Meta-analysis. What have we discovered? Damage. 2023;54(Suppl 3):S30–4.
Wang XM, et al. A short introduction of meta-analyses in medical follow and analysis. J Gene Med. 2021;23(5): e3312.
Peng T, et al. Rational design of oral supply nanosystems for hypoglycemic peptides. Nano Immediately. 2023;53: 102031.
Web page MJ, et al. The PRISMA 2020 assertion: an up to date guideline for reporting systematic critiques. BMJ. 2021;372: n71.
Morgan RL, et al. Figuring out the PECO: a framework for formulating good inquiries to discover the affiliation of environmental and different exposures with well being outcomes. Environ Int. 2018;121(Pt 1):1027–31.
Guyatt GH, et al. GRADE tips: 2. Framing the query and deciding on essential outcomes. J Clin Epidemiol. 2011;64(4):395–400.
Ouzzani M, et al. Rayyan-a net and cellular app for systematic critiques. Syst Rev. 2016;5(1):210.
Tiloke C, Phulukdaree A, Chuturgoon AA. The chemotherapeutic potential of gold nanoparticles towards human carcinomas: a overview. In: Andrew W, editor. Nanoarchitectonics for good supply and drug focusing on. New York: Elsevier; 2016. p. 783–811.
Badwaik H, et al. Phytoconstituent plumbagin: chemical, biotechnological and pharmaceutical facets. In: Research in pure merchandise chemistry. New York: Elsevier; 2019. p. 415–60.
ImageJ. [cited 01/07/2024; Available from: https://imagej.net/ij/.
The jamovi project. jamovi (Version 2.3) [Computer Software]. Out there from: https://www.jamovi.org.
Cochrane.org. Chapter 10: Analysing information and endeavor meta-analyses. 2024; Out there from: https://coaching.cochrane.org/handbook/present/chapter-10.
Schneider A, Hommel G, Blettner M. Linear regression evaluation: half 14 of a collection on analysis of scientific publications. Dtsch Arztebl Int. 2010;107(44):776–82.
Yeturu Ok, Srinivasa Rao ASR, Rao CR. Chapter 3—Machine studying algorithms, functions, and practices in information science. In: Ideas and strategies for information science. New York: Elsevier; 2020. p. 81–206.
Hooijmans CR, et al. SYRCLE’s threat of bias device for animal research. BMC Med Res Methodol. 2014;14:43.
Raguraman V, Jayasri MA, Suthindhiran Ok. Magnetosome mediated oral Insulin supply and its potential use in diabetes administration. J Mater Sci Mater Med. 2020;31(8):75.
Li Y, et al. Cost-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for environment friendly oral insulin supply. Theranostics. 2021;11(9):4452–66.
Li L, et al. Preparation of chitosan-based multifunctional nanocarriers overcoming a number of limitations for oral supply of insulin. Mater Sci Eng C Mater Biol Appl. 2017;70(Pt 1):278–86.
Sheng J, et al. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming a number of limitations to oral insulin absorption. ACS Appl Mater Interfaces. 2015;7(28):15430–41.
Guo H, et al. Phenylboronic acid-based amphiphilic glycopolymeric nanocarriers for in vivo insulin supply. Polym Chem. 2016;7:3189–99.
Sheng J, et al. Enhancing insulin oral absorption through the use of mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. J Management Launch. 2016;233:181–90.
Solar S, et al. Multifunctional composite microcapsules for oral supply of insulin. Int J Mol Sci. 2016;18(1):54.
Kim KS, et al. Immense insulin intestinal uptake and lymphatic transport utilizing bile acid conjugated partially uncapped liposome. Mol Pharm. 2018;15(10):4756–63.
Kim JU, et al. Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin supply utilizing response floor methodology. Int J Pharm. 2020;588: 119736.
Alibolandi M, et al. Dextran-b-poly(lactide-co-glycolide) polymersome for oral supply of insulin: in vitro and in vivo analysis. J Management Launch. 2016;227:58–70.
Al-Remawi M, et al. Chitosan/lecithin liposomal nanovesicles as an oral insulin supply system. Pharm Dev Technol. 2017;22(3):390–8.
Amaral M, et al. How can biomolecules enhance mucoadhesion of oral insulin? A complete perception utilizing. Biomolecules. 2020;10(5):675.
Bai Y, et al. Nanoparticles with floor options of dendritic oligopeptides as potential oral drug supply methods. J Mater Chem B. 2020;8(13):2636–49.
Balabushevich NG, et al. Layer-by-layer adsorption of biopolyelectrolytes as a common method to fabrication of protein-loaded microparticles. Moscow College Chemistry Bulletin. 2014.
Chen T, et al. Self-assembly pH-sensitive chitosan/alginate coated polyelectrolyte complexes for oral supply of insulin. J Microencapsul. 2019;36(1):96–107.
Chen X, et al. Cp1-11 peptide/insulin advanced loaded pH-responsive nanoparticles with enhanced oral bioactivity. Int J Pharm. 2019;562:23–30.
Cho HJ, et al. Chondroitin sulfate-capped gold nanoparticles for the oral supply of insulin. Int J Biol Macromol. 2014;63:15–20.
Elsayed AM, et al. Low molecular weight chitosan–insulin complexes solubilized in a combination of self-assembled labrosol and plurol oleaque and their glucose discount exercise in rats. Mar Medicine. 2018;16(1):32.
El Leithy ES, Abdel-Bar HM, Ali RA. Folate-chitosan nanoparticles triggered insulin mobile uptake and improved in vivo hypoglycemic exercise. Int J Pharm. 2019;571: 118708.
Fang Y, et al. Gastrointestinal responsive polymeric nanoparticles for oral supply of insulin: optimized preparation, characterization, and in vivo analysis. J Pharm Sci. 2019;108(9):2994–3002.
Gao Y, et al. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral supply of protein medication by overcoming a number of gastrointestinal limitations. J Colloid Interface Sci. 2021;582(Pt A):364–75.
He H, et al. VB12-coated Gel-Core-SLN containing insulin: one other approach to enhance oral absorption. Int J Pharm. 2015;493(1–2):451–9.
He Z, et al. Scalable manufacturing of core–shell nanoparticles by flash nanocomplexation to boost mucosal transport for oral supply of insulin. Nanoscale. 2018;10(7):3307–19.
Hu Y, Wang J, Qiu L. Polymeric nano-vesicles by way of intermolecular motion to load and orally ship insulin with enhanced hypoglycemic impact. RSC Adv. 2020;10(13):7887–97.
Inchaurraga L, et al. Zein-based nanoparticles for the oral supply of insulin. Drug Deliv Transl Res. 2020;10(6):1601–11.
Jin Y, et al. Chitosan modified cerasomes incorporating poly (vinyl pyrrolidone) for oral insulin supply. RSC Adv. 2014;4:58137–44.
Kassem M, et al. Formulation, characterization and in vivo utility of oral insulin nanotechnology utilizing completely different biodegradable polymers: superior drug supply system. Int J Pharm Sci Res. 2018;9:3664–77.
Kumari Y, et al. Modified apple polysaccharide capped gold nanoparticles for oral supply of insulin. Int J Biol Macromol. 2020;149:976–88.
Lee JH, et al. ZOT-derived peptide and chitosan functionalized nanocarrier for oral supply of protein drug. Biomaterials. 2016;103:160–9.
Lee SH, et al. Enhanced oral supply of insulin by way of the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit. J Nanobiotechnol. 2020;18(1):104.
Li X, et al. Intestinal mucosa permeability following oral insulin supply utilizing core shell corona nanolipoparticles. Biomaterials. 2013;34(37):9678–87.
Li J, et al. The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin supply. Acta Pharm Sin B. 2022;12(3):1460–72.
Liu L, et al. Self-assembled lecithin/chitosan nanoparticles for oral insulin supply: preparation and useful analysis. Int J Nanomed. 2016;11:761–9.
Liu C, et al. A novel ligand conjugated nanoparticles for oral insulin supply. Drug Deliv. 2016;23(6):2015–25.
Liu M, et al. Environment friendly mucus permeation and tight junction opening by dissociable “mucus-inert” agent coated trimethyl chitosan nanoparticles for oral insulin supply. J Management Launch. 2016;222:67–77.
Liu L, et al. Twin stimuli-responsive nanoparticle-incorporated hydrogels as an oral insulin provider for intestine-targeted supply and enhanced paracellular permeation. ACS Biomater Sci Eng. 2018;4(8):2889–902.
Liu M, et al. Iron-mimic peptide converts transferrin from foe to pal for orally focusing on insulin supply. J Mater Chem B. 2018;6(4):593–601.
Liu X, et al. Angiopep-2-functionalized nanoparticles improve transport of protein medication throughout intestinal epithelia by self-regulation of focused receptors. Biomater Sci. 2021;9(8):2903–16.
Lopes M, et al. In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the therapy of sort 1 and sort 2 diabetes. Eur J Pharm Biopharm. 2017;113:88–96.
Martínez-López AL, et al. Arabinoxylans-based oral insulin supply system focusing on the colon: simulation in a human intestinal microbial ecosystem and analysis in diabetic rats. Prescription drugs (Basel). 2022;15(9):1062.
Mudassir J, et al. Self-assembled insulin and nanogels polyelectrolyte advanced (Ins/NGs-PEC) for oral insulin supply: characterization, lyophilization and in-vivo analysis. Int J Nanomed. 2019;14:4895–909.
Mutlu-Agardan NB, Han S. In vitro and in vivo evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin supply. Pharm Dev Technol. 2021;26(2):157–66.
Paul PK, Treetong A, Suedee R. Biomimetic insulin-imprinted polymer nanoparticles as a possible oral drug supply system. Acta Pharm. 2017;67(2):149–68.
Rao R, et al. Bioinspired zwitterionic polyphosphoester modified porous silicon nanoparticles for environment friendly oral insulin supply. Biomater Sci. 2021;9(3):685–99.
Reboredo C, et al. Zein-based nanoparticles as oral carriers for insulin supply. Pharmaceutics. 2021;14(1):39.
Rekha MR, Sharma C. Simultaneous impact of thiolation and carboxylation of chitosan particles in the direction of mucoadhesive oral insulin supply functions: an in vitro and in vivo analysis. J Biomed Nanotechnol. 2015;11:11.
Shan W, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral supply of insulin. ACS Nano. 2015;9(3):2345–56.
Shan W, et al. Enhanced oral supply of protein medication utilizing zwitterion-functionalized nanoparticles to beat each the diffusion and absorption limitations. ACS Appl Mater Interfaces. 2016;8(38):25444–53.
Situ W, et al. Preparation and characterization of glycoprotein-resistant starch advanced as a coating materials for oral bioadhesive microparticles for colon-targeted polypeptide supply. J Agric Meals Chem. 2015;63(16):4138–47.
Sonia TA, Sharma CP. pH delicate thiolated cationic hydrogel for oral insulin supply. J Biomed Nanotechnol. 2014;10(4):642–50.
Sudhakar S, et al. Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral supply of insulin in vivo. Int J Biol Macromol. 2020;150:281–8.
Solar L, et al. Oral glucose- and pH-sensitive nanocarriers for simulating insulin launch in vivo. Polym Chem. 2014;5:1999–2009.
Solar L, et al. Scalable manufacturing of enteric encapsulation methods for site-specific oral insulin supply. Biomacromol. 2019;20(1):528–38.
Tan X, et al. Hydrophilic and electroneutral nanoparticles to beat mucus trapping and improve oral supply of insulin. Mol Pharm. 2020;17(9):3177–91.
Urimi D, et al. Polyglutamic acid functionalization of chitosan nanoparticles enhances the therapeutic efficacy of insulin following oral administration. AAPS PharmSciTech. 2019;20(3):131.
Verma A, et al. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and pH responsive provider for improved oral supply of insulin. Acta Biomater. 2016;31:288–300.
Wang S, et al. pH-responsive and mucoadhesive nanoparticles for enhanced oral insulin supply: the impact of hyaluronic acid with completely different molecular weights. Pharmaceutics. 2023;15(3):820.
Wu S, et al. A supply system for oral administration of proteins/peptides via bile acid transport channels. J Pharm Sci. 2019;108(6):2143–52.
Xing L, et al. Complying with the physiological capabilities of Golgi equipment for secretory exocytosis facilitated oral absorption of protein medication. J Mater Chem B. 2021;9(6):1707–18.
Xu Y, et al. Novel strong lipid nanoparticle with endosomal escape perform for oral supply of insulin. ACS Appl Mater Interfaces. 2018;10(11):9315–24.
Zhang ZH, et al. N-octyl-N-Arginine chitosan micelles as an oral supply system of insulin. J Biomed Nanotechnol. 2013;9(4):601–9.
Zhang P, et al. Goblet cell focusing on nanoparticle containing drug-loaded micelle cores for oral supply of insulin. Int J Pharm. 2015;496(2):993–1005.
Zhang L, et al. Preparation and characterization of layer-by-layer hypoglycemic nanoparticles with pH-sensitivity for oral insulin supply. J Mater Chem B. 2018;6(45):7451–61.
Zheng Y, et al. Multifunctional nanoparticles allow environment friendly oral supply of biomacromolecules by way of enhancing payload stability and regulating the transcytosis pathway. ACS Appl Mater Interfaces. 2018;10(40):34039–49.
Zhou Y, et al. A nanocomposite car based mostly on steel–natural framework nanoparticle included biodegradable microspheres for enhanced oral insulin supply. ACS Appl Mater Interfaces. 2020;12(20):22581–92.
Zhou S, et al. Thiolated nanoparticles overcome the mucus barrier and epithelial barrier for oral supply of insulin. Mol Pharm. 2020;17(1):239–50.
Zhou X, et al. Oral supply of insulin with clever glucose-responsive swap for blood glucose regulation. J Nanobiotechnol. 2020;18(1):96.
Chaturvedi Ok, et al. Oral insulin supply utilizing deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles. Nanomedicine (Lond). 2015;10(10):1569–83.
Cui Y, et al. The mix of endolysosomal escape and basolateral stimulation to beat the difficulties of “straightforward uptake arduous transcytosis” of ligand-modified nanoparticles in oral drug supply. Nanoscale. 2018;10(3):1494–507.
Hu XB, et al. Phospholipid advanced based mostly nanoemulsion system for oral insulin supply: preparation, in vitro, and in vivo evaluations. Int J Nanomed. 2019;14:3055–67.
Wu L, et al. Bioinspired butyrate-functionalized nanovehicles for focused oral supply of biomacromolecular medication. J Management Launch. 2017;262:273–83.
Wu J, et al. Biomimetic viruslike and cost reversible nanoparticles to sequentially overcome mucus and epithelial limitations for oral insulin supply. ACS Appl Mater Interfaces. 2018;10(12):9916–28.
Wu L, et al. Selling apical-to-basolateral unidirectional transport of nanoformulations by manipulating the nutrient-absorption pathway. J Management Launch. 2020;323:151–60.
Zhao X, et al. Preparation, characterization, and analysis in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral supply of insulin. Int J Pharm. 2013;454(1):278–84.
Cui Y, et al. A technique for creating efficient orally-delivered nanoparticles via modulation of the floor “hydrophilicity/hydrophobicity steadiness.” J Mater Chem B. 2017;5(6):1302–14.
Ding Y, et al. Ldl cholesterol moieties as constructing blocks for assembling nanoparticles to realize efficient oral supply of insulin. Biomater Sci. 2020;8(14):3979–93.
Guha A, et al. pH responsive cylindrical MSN for oral supply of insulin-design, fabrication and analysis. Drug Deliv. 2016;23(9):3552–61.
Jia X, et al. Multi-functional self-assembly nanoparticles originating from small molecule pure product for oral insulin supply via modulating tight junctions. J Nanobiotechnol. 2022;20(1):116.
Liu L, et al. pH- and amylase-responsive carboxymethyl starch/poly(2-isobutyl-acrylic acid) hybrid microgels as efficient enteric carriers for oral insulin supply. Biomacromol. 2018;19(6):2123–36.
Morales-Burgos AM, et al. Extremely cross-linked arabinoxylans microspheres as a microbiota-activated provider for colon-specific insulin supply. Eur J Pharm Biopharm. 2021;163:16–22.
Situ W, et al. Resistant starch film-coated microparticles for an oral colon-specific polypeptide supply system and its launch behaviors. J Agric Meals Chem. 2014;62(16):3599–609.
Zeng Z, et al. Scalable manufacturing of therapeutic protein nanoparticles utilizing flash nanoprecipitation. Adv Healthc Mater. 2019;8(6): e1801010.
Turner PV, et al. Administration of gear to laboratory animals: routes of administration and components to think about. J Am Assoc Lab Anim Sci. 2011;50(5):600–13.
Kovshova T, et al. Optimization of strategies for dedication of the encapsulation effectivity of doxorubicin within the nanoparticles based mostly on poly(lactic-co-glycolic acid) (PLGA). Drug Dev Regis. 2020;9:113–8.
Kamelnia R, et al. Bettering the soundness of insulin via efficient chemical modifications: a complete overview. Int J Pharm. 2024;661: 124399.
Alfatama M, et al. A complete overview of oral chitosan drug supply methods: functions for oral insulin supply. Nanotechnol Rev. 2024;13(1):20230205.
Caturano A, et al. Advances in Nanomedicine for Precision Insulin Supply. Prescription drugs (Basel). 2024;17(7):945.
Bhumkar DR, et al. Chitosan diminished gold nanoparticles as novel carriers for transmucosal supply of insulin. Pharm Res. 2007;24(8):1415–26.
Bloomgarden Z. Novel approaches to the therapy of sort 1 diabetes. J Diabetes. 2022;14(11):724–6.
Fujikawa T. Central regulation of glucose metabolism in an insulin-dependent and -independent method. J Neuroendocrinol. 2021;33(4): e12941.
Dube S, et al. Evaluation of insulin motion on carbohydrate metabolism: physiological and non-physiological strategies. Diabet Med. 2013;30(6):664–70.
Adeva-Andany MM, et al. Glycogen metabolism in people. BBA Clin. 2016;5:85–100.
Franco NH. Animal experiments in biomedical analysis: a historic perspective. Animals (Basel). 2013;3(1):238–73.
Scridon A, et al. Wistar rats with long-term streptozotocin-induced sort 1 diabetes mellitus replicate essentially the most related medical, biochemical, and hematologic options of human diabetes / Sobolanii Wistar cu diabet zaharat tip 1 indus cu streptozotocina reproduc cele mai relevante caracteristici clinice, biochimice si hematologice ale diabetului uman. Revista Romana de Medicina de Laborator. 2015. 23.
Nagy G, et al. New therapeutic approaches for sort 1 diabetes: Illness-modifying therapies. World J Diabetes. 2022;13(10):835–50.
Winkel L, et al. Fetal programming of the endocrine pancreas: influence of a maternal low-protein eating regimen on gene expression within the perinatal rat pancreas. Int J Mol Sci. 2022;23:11057. https://doi.org/10.3390/ijms231911057.
Ghasemi A, Jeddi S, Kashfi Ok. The laboratory rat: age and physique weight matter. EXCLI J. 2021;20:1431–45.
Iannaccone PM, Jacob HJ. Rats! Dis Mannequin Mech. 2009;2(5–6):206–10.
Zhu D. Benefits and drawbacks of various insulin administration strategies for the therapy of diabetes. Adv Humanit Res. 2023;3:311–5.
Wang M, et al. Versatile oral insulin supply nanosystems: from supplies to nanostructures. Int J Mol Sci. 2022;23(6):3362.
Rekha MR, Sharma CP. Oral supply of therapeutic protein/peptide for diabetes–future views. Int J Pharm. 2013;440(1):48–62.
Jain KK. An summary of drug supply methods. Strategies Mol Biol. 2020;2059:1–54.
Seyam S, Nordin NA, Alfatama M. Current progress of chitosan and chitosan derivatives-based nanoparticles: pharmaceutical views of oral insulin supply. Prescription drugs (Basel). 2020;13(10):307.
Richter B, Neises G. “Human” insulin versus animal insulin in individuals with diabetes mellitus. Cochrane Database Syst Rev. 2005;2005(1): CD003816.
Hirst JA, et al. The necessity for randomization in animal trials: an outline of systematic critiques. PLoS ONE. 2014;9(6): e98856.
Kahan BC, Rehal S, Cro S. Threat of choice bias in randomised trials. Trials. 2015;16:405.
Danaei M, et al. Affect of particle measurement and polydispersity index on the medical functions of lipidic nanocarrier methods. Pharmaceutics. 2018;10(2):57.
Yang Ok, et al. Polymers and inorganic nanoparticles: a profitable mixture in the direction of assembled nanostructures for most cancers imaging and remedy. Nano Toady. 2021;36: 101046.
Biriukov D, Fibich P, Předota M. Zeta potential dedication from molecular simulations. J Phys Chem C. 2020;124(5):3159–70.
Eldridge JA, et al. Nanoparticle ζ-potential measurements utilizing tunable resistive pulse sensing with variable strain. J Colloid Interface Sci. 2014;429:45–52.
Xu J, et al. Functions and challenges of ultra-small particle measurement nanoparticles in tumor remedy. J Management Launch. 2023;353:699–712.
ACTTR. What Does “Span” of Particle Dimension Imply? 2020; Out there from: https://www.acttr.com/en/en-faq/en-faq-particle-size-analyzer/411-en-faq-particle-span-meaning.html.
Liu Y, et al. Growth of high-drug-loading nanoparticles. ChemPlusChem. 2020;85(9):2143–57.
Gordillo-Galeano A, Mora-Huertas CE. Strong lipid nanoparticles and nanostructured lipid carriers: a overview emphasizing on particle construction and drug launch. Eur J Pharm Biopharm. 2018;133:285–308.
Lankalapalli S, Kolapalli VR. Polyelectrolyte complexes: a overview of their applicability in drug supply know-how. Indian J Pharm Sci. 2009;71(5):481–7.
Ankerfors C. Polyelectrolyte complexes: preparation, characterization, and use for management of moist and dry adhesion between surfaces. In: Chemical science and engineering. 2012, HTJ: Stockholm. p. 58.
Wong CY, Al-Salami H, Dass CR. Fabrication methods for the preparation of orally administered insulin nanoparticles. J Drug Goal. 2021;29(4):365–86.
Guadarrama-Escobar OR, et al. Chitosan nanoparticles as oral drug carriers. Int J Mol Sci. 2023;24(5):4289.
Xiao Y, et al. Oral insulin supply platforms: methods to handle the organic limitations. Angew Chem Int Ed Engl. 2020;59(45):19787–95.
Langguth P, et al. The problem of proteolytic enzymes in intestinal peptide supply. J Management Launch. 1997;46(1–2):18.
Alai MS, Lin WJ, Pingale SS. Utility of polymeric nanoparticles and micelles in insulin oral supply. J Meals Drug Anal. 2015;23(3):351–8.
Lemmer HJ, Hamman JH. Paracellular drug absorption enhancement via tight junction modulation. Knowledgeable Opin Drug Deliv. 2013;10(1):103–14.
Shaikh R, et al. Mucoadhesive drug supply methods. J Pharm Bioallied Sci. 2011;3(1):89–100.
Makhlof A, Tozuka Y, Takeuchi H. Design and analysis of novel pH-sensitive chitosan nanoparticles for oral insulin supply. Eur J Pharm Sci. 2011;42(5):445–51.
Dieterich W, Schink M, Zopf Y. Microbiota within the gastrointestinal tract. Med Sci (Basel). 2018;6(4):116.
Sousa de Almeida M, et al. Understanding nanoparticle endocytosis to enhance focusing on methods in nanomedicine. Chem Soc Rev. 2021;50(9):5397–434.
Meneguin AB, et al. The position of polysaccharides from pure sources to design oral insulin micro- and nanoparticles meant for the therapy of diabetes mellitus: a overview. Carbohydr Polym. 2021;256: 117504.
Lopes MA, et al. Intestinal uptake of insulin nanoparticles: details or myths? Curr Pharm Biotechnol. 2014;15(7):629–38.
Barfar A, et al. Oral insulin supply: a overview on current developments and novel methods. Curr Drug Deliv. 2024;21(6):887–900.
Costa C, et al. All-in-one microfluidic meeting of insulin-loaded pH-responsive nano-in-microparticles for oral insulin supply. Biomater Sci. 2020;8(12):3270–7.
Noticed PE, et al. Stimuli-responsive polymer-prodrug hybrid nanoplatform for multistage siRNA supply and mixture most cancers remedy. Nano Lett. 2019;19(9):5967–74.
Chen J, et al. Advances in nanomaterials for photodynamic remedy functions: standing and challenges. Biomaterials. 2020;237: 119827.
Liu X, et al. Multifunctional nano-in-micro supply methods for focused remedy in fundus neovascularization illnesses. J Nanobiotechnol. 2024;22(1):354.
Bikram M, et al. Temperature-sensitive hydrogels with SiO2-Au nanoshells for managed drug supply. J Management Launch. 2007;123(3):219–27.
Richter B, Bongaerts B, Metzendorf MI. Thermal stability and storage of human insulin. Cochrane Database Syst Rev. 2023;11(11):CD015385.
Shorten PR, McMahon CD, Soboleva TK. Insulin transport inside skeletal muscle transverse tubule networks. Biophys J. 2007;93(9):3001–7.
Hyperlink FJ, Heng JYY. Unraveling the influence of pH on the crystallization of pharmaceutical proteins: a case research of human insulin. Cryst Development Des. 2022;22(5):3024–33.
Heerklotz H. Interactions of surfactants with lipid membranes. Q Rev Biophys. 2008;41(3–4):205–64.
Parsi Ok. Interplay of detergent sclerosants with cell membranes. Phlebology. 2015;30(5):306–15.
Venkatesan J, et al. Seaweed polysaccharide-based nanoparticles: preparation and functions for drug supply. Polymers (Basel). 2016;8(2):30.
